Exelis Inc. |
||||||
Condensed Consolidated Statements of Cash Flows (unaudited) |
||||||
(IN MILLIONS) |
||||||
Three Months Ended March 31, | ||||||
2014 | 2013 | |||||
Operating activities | ||||||
Net income | $ | 52 | $ | 44 | ||
Adjustments to reconcile net income to net cash used in operating activities: | ||||||
Depreciation and amortization | 27 | 27 | ||||
Stock-based compensation | 8 | 5 | ||||
Restructuring and asset impairment charges | 5 | 49 | ||||
Payments for restructuring | (11) | (6) | ||||
Defined benefit plans expense | 17 | 26 | ||||
Defined benefit plans payments | (42) | (39) | ||||
Change in assets and liabilities | ||||||
Change in receivables | (84) | (27) | ||||
Change in inventories | (21) | (17) | ||||
Change in other assets | — | (3) | ||||
Change in accounts payable | (42) | (77) | ||||
Change in advance payments and billings in excess of costs | (29) | 6 | ||||
Change in deferred taxes | 14 | 18 | ||||
Change in other liabilities | (49) | (72) | ||||
Other, net | (3) | 1 | ||||
Net cash used in operating activities | (158) | (65) | ||||
Investing activities | ||||||
Capital expenditures | (7) | (17) | ||||
Proceeds from the sale of assets | 3 | — | ||||
Acquisitions, net of cash acquired | — | (15) | ||||
Net cash used in investing activities | (4) | (32) | ||||
Financing activities | ||||||
Dividends paid | (20) | — | ||||
Common stock repurchased | (24) | — | ||||
Proceeds from the exercise of stock options | 12 | 1 | ||||
Other, net | 5 | (2) | ||||
Net cash used in financing activities | (27) | (1) | ||||
Exchange rate effects on cash and cash equivalents | — | (9) | ||||
Net change in cash and cash equivalents | (189) | (107) | ||||
Cash and cash equivalents – beginning of year | 469 | 292 | ||||
Cash and cash equivalents – end of period | $ | 280 | $ | 185 | ||